Vir Biotechnology, Inc. Annual Income Tax Expense (Benefit) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Vir Biotechnology, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2017 to 2023.
  • Vir Biotechnology, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$1.51M, a 46.9% increase year-over-year.
  • Vir Biotechnology, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$9.23M, a 102% decline year-over-year.
  • Vir Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2023 was -$13.1M, a 105% decline from 2022.
  • Vir Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2022 was $238M, a 1024% increase from 2021.
  • Vir Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2021 was $21.2M, a 39193% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$13.1M -$252M -105% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $238M +$217M +1024% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $21.2M +$21.2M +39193% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $54K -$100K -64.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $154K +$634K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$480K +$10.4M +95.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$10.9M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.